EP3341409
Lífefnalyfjasamsetningar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
22.8.2016EP published:
25.2.2026EP application number:
16760801.7
EP translation filed:
29.4.2026Grant published:
13.5.2026EPO information:
European Patent Register
Max expiry date:
21.8.2036Expiry date:
21.8.2026
Title in English:
BIOPHARMACEUTICAL COMPOSITIONSLanguage of the patent:
English
Timeline
Today
22.8.2016EP application
25.2.2026EP Publication
29.4.2026Translation submitted
13.5.2026Registration published
21.8.2026Expires
Owner
Name:
GlaxoSmithKline Intellectual Property (No.2) LimitedAddress:
GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY, GB
Inventor
Name:
MONCK, Myrna A.Address:
King of Prussia, PA 19406, US
Name:
BAM, Narendra B.Address:
King of Prussia, PA 19406, US
Name:
DALLY, JenniferAddress:
King of Prussia, PA 19406, US
Name:
SPATARA, MichelleAddress:
King of Prussia, PA 19406, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562209000 PDate:
24.8.2015Country:
US
Number:
201562240131 PDate:
12.10.2015Country:
US
Number:
201562247906 PDate:
29.10.2015Country:
US
Number:
201562249497 PDate:
2.11.2015Country:
US
Classification
Categories:
C07K 16/24, C07K 1/16